188 related articles for article (PubMed ID: 7004201)
1. Surfactant apoprotein in nonmalignant pulmonary disorders.
Singh G; Katyal SL
Am J Pathol; 1980 Oct; 101(1):51-61. PubMed ID: 7004201
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary alveolar proteinosis. Staining for surfactant apoprotein in alveolar proteinosis and in conditions simulating it.
Singh G; Katyal SL; Bedrossian CW; Rogers RM
Chest; 1983 Jan; 83(1):82-6. PubMed ID: 6336692
[TBL] [Abstract][Full Text] [Related]
3. Immunohistological analysis of surfactant-apoprotein in the bronchiolo-alveolar carcinoma.
Dairaku M; Sueishi K; Tanaka K; Horie A
Virchows Arch A Pathol Anat Histopathol; 1983; 400(3):223-34. PubMed ID: 6310856
[TBL] [Abstract][Full Text] [Related]
4. Diffuse alveolar damage and acute interstitial pneumonitis: histochemical evaluation with lectins and monoclonal antibodies against surfactant apoprotein and collagen type IV.
Sugiyama K; Kawai T
Mod Pathol; 1993 May; 6(3):242-8. PubMed ID: 8346171
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of surfactant apoproteins in usual interstitial pneumonia associated with pulmonary carcinoma.
Chung JH; Kitaichi M; Ham EK; Seo JW
Microsc Res Tech; 1998 Aug; 42(3):234-8. PubMed ID: 9764924
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of human pulmonary surfactant apoproteins with monoclonal antibodies. Pathologic application for hyaline membrane disease.
Kuroki Y; Dempo K; Akino T
Am J Pathol; 1986 Jul; 124(1):25-33. PubMed ID: 3524252
[TBL] [Abstract][Full Text] [Related]
7. Characterization of amiodarone pneumonitis as related to inflammatory cells and surfactant apoprotein.
Nagata N; Suematsu R; Yoshii C; Miyazaki H; Sueishi K; Kido M
Chest; 1997 Oct; 112(4):1068-74. PubMed ID: 9377919
[TBL] [Abstract][Full Text] [Related]
8. Intracellular metabolism of the apoproteins of pulmonary surfactant in rat lung.
King RJ; Martin H
J Appl Physiol Respir Environ Exerc Physiol; 1980 May; 48(5):812-20. PubMed ID: 6893834
[TBL] [Abstract][Full Text] [Related]
9. Congenital alveolar proteinosis in the Netherlands: a report of five cases with immunohistochemical and genetic studies on surfactant apoproteins.
de la Fuente AA; Voorhout WF; deMello DE
Pediatr Pathol Lab Med; 1997; 17(2):221-31. PubMed ID: 9086529
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity of surfactant-apoprotein in adenocarcinomas, large cell and small cell carcinomas of the lung.
Kitinya JN; Sueishi K; Tanaka K; Katsuda Y
Acta Pathol Jpn; 1986 Sep; 36(9):1271-8. PubMed ID: 3024446
[TBL] [Abstract][Full Text] [Related]
11. Surfactant protein D. Increased accumulation in silica-induced pulmonary lipoproteinosis.
Crouch E; Persson A; Chang D; Parghi D
Am J Pathol; 1991 Oct; 139(4):765-76. PubMed ID: 1656758
[TBL] [Abstract][Full Text] [Related]
12. Determination of fetal age by immunohistochemical estimation of surfactant-producing alveolar type II cells.
Betz P; Nerlich A; Wilske J; Wiest I; Kunze C; Peschel O; Penning R
Forensic Sci Int; 1992 Mar; 53(2):193-202. PubMed ID: 1592328
[TBL] [Abstract][Full Text] [Related]
13. Sclerosing hemangioma of the lung. Immunohistochemical characterization of its origin as related to surfactant apoprotein.
Nagata N; Dairaku M; Ishida T; Sueishi K; Tanaka K
Cancer; 1985 Jan; 55(1):116-23. PubMed ID: 2981138
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of monoclonal antibody against human pulmonary surfactant apoprotein.
Takeda K; Mizusawa I; Kuroda Y; Hiraiwa K
Tohoku J Exp Med; 1988 Jan; 154(1):37-46. PubMed ID: 3284001
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma of type II pneumocytes. PAS staining as a screening test for nuclear inclusions of surfactant specific apoprotein.
Singh G; Katyal SL; Torikata C
Cancer; 1982 Sep; 50(5):946-8. PubMed ID: 6178499
[TBL] [Abstract][Full Text] [Related]
16. Sclerosing hemangioma of the lung. An epithelial tumor composed of immunohistochemically heterogenous cells.
Nagata N; Dairaku M; Sueishi K; Tanaka K
Am J Clin Pathol; 1987 Nov; 88(5):552-9. PubMed ID: 2823596
[TBL] [Abstract][Full Text] [Related]
17. Surfactant proteins in pulmonary alveolar proteinosis in adults.
Brasch F; Birzele J; Ochs M; Guttentag SH; Schoch OD; Boehler A; Beers MF; Müller KM; Hawgood S; Johnen G
Eur Respir J; 2004 Sep; 24(3):426-35. PubMed ID: 15358702
[TBL] [Abstract][Full Text] [Related]
18. Intratracheally applied rSP-C surfactant exhibits no anaphylactic shock reactions in a guinea pig model of acute lung hypersensitivity.
Germann PG; Kemkowski J; Hauschke D; Steinhilber W; Häfner D
Exp Toxicol Pathol; 1999 Nov; 51(6):495-505. PubMed ID: 10661808
[TBL] [Abstract][Full Text] [Related]
19. [Morphologic findings on the formal genesis of pulmonary alveolar proteinosis].
Eckert H; Dehnert I
Z Erkr Atmungsorgane; 1984; 162(1):36-44. PubMed ID: 6372272
[TBL] [Abstract][Full Text] [Related]
20. Surfactant apoprotein-A concentration in sputum for diagnosis of pulmonary alveolar proteinosis.
Masuda T; Shimura S; Sasaki H; Takishima T
Lancet; 1991 Mar; 337(8741):580-2. PubMed ID: 1671943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
